Improving medication adherence in patients with chronic diseases

Not Applicable

Completed

• Conditions: Hypertension; Dyslipidaemia; Type II Diabetes; Other cardiovascular diseases; Cardiovascular - Hypertension; Cardiovascular - Other cardiovascular diseases; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12613000162718
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients attending one of the study pharmacies
- Patients over 18 years of age
- Diagnosed with at least one of the following chronic diseases: hypertension, type 2 diabetes, dyslipidaemia or cardiovascular disease
- Patients taking a medication for one of the above chronic diseases from the following drug groups: ACE-inhibitors, calcium channel blockers, beta-blockers, oral hypoglycaemic drugs, lipid lowering agents
- Patients with a newly initiated medication (from above) within the previous four to twelve weeks
- Consent to participate in the study

Exclusion Criteria

- Patients who do not adequately understand the study information (in the opinion of the researcher)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medication adherence as assessed by mean MAQ (Medication Adherence Questionnaire) scores[Baseline and at 3 and 6 months after implementation of intervention at baseline]

Secondary Outcome Measures

Name	Time	Method
Changes in adherence behaviour over time as assessed by individual mean MAQ scores[Baseline and at 3 and 6 months after implementation of intervention at baseline]